Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo
NCT04971200
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Skin and Connective Tissue Diseases
Skin Diseases
Pigmentation Disorder
Hypopigmentation
Biologic
Vitiligo
Interventions
DRUG:
Tildrakizumab
Sponsor
Premier Specialists, Australia